January 17, 2012 News release
news
Teenagers are more susceptible to developing disorders like addiction and depression, according to a new paper published by University of Pittsburgh researchers.
December 21, 2011 Gary Enos, Editor
blog
Multiple medication options are now in development as possible breakthroughs in the treatment of cocaine addiction.
November 17, 2011 Jerry Rand, MD
article
Benzodiazepines are prescribed for a variety of illnesses, including anxiety disorders but also used in cases of schizophrenia, depression, polysubstance abuse, alcohol withdrawal and other disorders.
November 17, 2011 Shawn K. Hatch, ACSW, LMSW, CCS, CAADC
article
A client application process helps to preserve the treatment in a Michigan program.
November 9, 2011 Gary A. Enos, Editor
article
The first known randomized controlled study of medication treatment for patients dependent on prescription opioids demands a careful read, suggests its lead researcher, since disappointing results for counseling as an adjunct to medication should not be interpreted as diminishing any role for talk therapy.
July 14, 2011 Christina M. Delos Reyes, MD
article
Alcohol and other substance use disorders have been recognized by the American Medical Association (AMA) as diseases since the mid-1960s. Despite this fact, the treatment of substance use disorders has remained largely segregated to free-standing substance abuse treatment centers, which rarely employ physicians and other medical staff.
June 8, 2011 Gary A. Enos, Editor
article
The events of Thursday, June 2 offered the quintessential example of how marijuana policy has so many parties tied in knots these days. On the same
May 14, 2011 Alison Knopf
article
Disulfiram, naltrexone, acamprosate, methadone, buprenorphine-the medications approved to treat addiction literally can be counted on the fingers of
February 28, 2011 Dennis Grantham, Senior Editor
article
Former U.S. drug czar General Barry McCaffrey and the CEO of CRC Health Group, Andy Eckert (pictured left), today announced their support for new
February 1, 2011 Gary A. Enos, Editor
article
In my September/October 2010 column I asked about whether tough financial times had left treatment center administrators contemplating business
February 1, 2011 Erik W. Gunderson, MD and Adam J. Gordon, MD, MPH, FACP, FASAM
article
Erik W. Gunderson, MD We read with great interest Steven R. Scanlan, MD's article “Suboxone: concerns behind the miracle” (November/December 2010
January 27, 2011 Gary A. Enos, Editor
article
The makers of Vivitrol, the once-monthly injectable form of the medication naltrexone to treat alcohol dependence, believe results of a newly
